The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients.

NCT07740083 · tracked via the Priya Life Science Turkey tracker

Sponsor

Izmir Tinaztepe University

Phase

Not applicable

Started

2025-01-12

Last updated

2026-07-31

Condition(s) studied

Kidney DiseaseChronc Kidney Disease Stage 5Chronic Kidney Disease

Investigational drug(s) / intervention(s)

Artificial Intelligence-Supported Patient Education

Artificial Intelligence-Supported Patient Education: The intervention consisted of an artificial intelligence-supported patient education program developed for patients with chronic kidney disease undergoing hemodialysis. The education focused on pruritus management and included information about the causes of itching, factors affecting pruritus, skin care, dietary recommendations, symptom management strategies, and self-management behaviors. The educational content was provided through an AI-supported website designed to improve patient empowerment and increase patients' knowledge and participation in their own care.

Study summary

This study investigates whether artificial intelligence-supported patient education can reduce itching and improve patient empowerment in individuals with chronic kidney disease undergoing hemodialysis.

Eligibility

Sex

ALL

Min age

18 Weeks

Max age

65 Weeks

Healthy volunteers

Inclusion Criteria: Patients with CKD. Patients who have ithing symptom. Patients who is older than 18. Patients who takes hemodylasis treatment regularly and in order. Exclusion Criteria: * Patients who got dementia and alzheimers. * Patients who is older than 65. * Patients who doesnt want to join the study.

Primary outcome measure(s)

5-D Itching Scale Score — 2 weeks
Changes in 5-D Itching Scale Score

Trial sites (1)

Facility	City	Region	Status
Nursing	Izmir	Ege

Other trials for the same condition

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria Recruiting

Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation Recruiting

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy Recruiting

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria Active, not recruiting

A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07740083 on ClinicalTrials.gov ↗ ← All trials in Turkey